In cancer cachexia, diminished PGC-1α expression in skeletal muscle has been consistently associated with mitochondrial dysfunction, impaired oxidative capacity, and exacerbated muscle wasting (111, 112). This evidence concerns the gene PPARGC1A and cancer.